STAT
JANUARY 17, 2024
Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.
STAT
OCTOBER 20, 2023
International Trade Commission against nearly a dozen online pharmacies that are allegedly selling unapproved versions of the Mounjaro diabetes drug, which is frequently used to combat obesity. As demand for weight-loss treatments intensifies, Eli Lilly has filed a complaint with the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
National Association of Boards of Pharmacy
MAY 1, 2024
Almost 75% of Americans are clinically defined as overweight or obese, and over 11% have diabetes. This class of drugs, with brand names like Ozempic, Wegovy, and Mounjaro, are approved to treat patients with diabetes and obesity. Many illegal online pharmacies belong to large, rogue online pharmacy networks.
National Association of Boards of Pharmacy
DECEMBER 13, 2023
Injectable diabetes medications including semaglutide, namely Wegovy and Ozempic, have been in shortage since 2022 , limiting patient access to the drug across the nation. Because Ozempic and Wegovy are commercially popular, illegal online sales of the products have increased dramatically.
STAT
OCTOBER 20, 2023
International Trade Commission against nearly a dozen online pharmacies that are allegedly selling unapproved versions of the Mounjaro diabetes drug, which is frequently used to combat obesity , STAT writes. As demand for weight-loss treatments intensifies, Eli Lilly has filed a complaint with the U.S.
Pharmaceutical Technology
MAY 26, 2023
The device received US Food and Drug Administration 510(k) clearance last week for those ages six years and above living with type 1 diabetes. The hands-off approach to diabetes management relies on Beta Bionic’s dosing algorithm. It will now be made at Convatec’s manufacturing sites in Mexico.
Pharmaceutical Technology
SEPTEMBER 7, 2022
Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market.
Expert insights. Personalized for you.
300 
Let's personalize your content